- within Environment topic(s)
Partner Mark Ford and Associate Kristen Parnigoni have authored a chapter in the American Bar Association's September/October 2025 issue of Landslide Magazine about how shifting the burden of proving good faith to pharmaceutical patent holders in antitrust cases may require waiver of the attorney-client privilege. They discuss the precedent set by other cases in this realm and key takeawaysabout the operation of the regulatory compliance defense in the context of Orange Bookantitrust cases in light of recent litigation.
To view the full article please click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.